210037-82-4

Basic information

• Product Name: 1,2-Benzenedicarbonitrile, 4-(hydroxymethyl)- (9CI)
• Synonyms: 1,2-Benzenedicarbonitrile, 4-(hydroxymethyl)- (9CI);4-(hydroxymethyl)-1,2-Benzenedicarbonitrile
• CAS NO: 210037-82-4
• Molecular Formula: C₉H₆N₂O
• Molecular Weight: 158.15674
• Product Categories: ALDEHYDE
• Mol File: 210037-82-4.mol
• Article Data: 5

Chemical Properties

• Melting Point: 70-72 °C
• Boiling Point: 406.5±40.0 °C(Predicted)
• Appearance: /
• Density: 1.27±0.1 g/cm3(Predicted)
• PKA: 13.63±0.10(Predicted)
• CAS DataBase Reference: 1,2-Benzenedicarbonitrile, 4-(hydroxymethyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2-Benzenedicarbonitrile, 4-(hydroxymethyl)- (9CI)(210037-82-4)
• EPA Substance Registry System: 1,2-Benzenedicarbonitrile, 4-(hydroxymethyl)- (9CI)(210037-82-4)

Safety Data

• Hazardous Substances Data: 210037-82-4(Hazardous Substances Data)

Usage

Synonyms

4-(hydroxymethyl)phthalonitrile

Derivative of

phthalonitrile

Usage

production of dyes, pigments, and polymers

Potential applications

pharmaceuticals and agricultural chemicals

Physical state

white crystalline solid

Melting point

172-175°C

Safety

should be handled and stored according to proper safety guidelines

Upstream product

• 313228-48-7 4-formyl-1,2-dicyanobenzene 
• 63089-50-9 4-methylphthalonitrile 

Relevant articles and documents

Synthesis and photophysical properties of fullerene-phthalocyanine- porphyrin triads and pentads

The synthesis and photophysical properties of several fullerene- phthalocyanine-porphyrin triads (1-3) and pentads (4-6) are described. The three photoactive moieties were covalently connected in an one-step synthesis through 1,3-dipolar cycloaddition to

Postfunctionalization of helical polyisocyanopeptides with phthalocyanine chromophores by "click chemistry"

Rigid rod polyisocyanopeptides bearing phthalocyanines as pendant groups have been synthesised through CuAAC of polyisocyanopeptides containing acetylene groups with zinc(II) phthalocyanine azide. As confirmed by UV/Vis, fluorescence, and circular dichroi

INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE

The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras.